FIELD: pharmaceutics.
SUBSTANCE: the suggested vaginal suppositories contain oxybutinine, estriol and lipophilic suppository foundation at certain ratio of components. The innovation enables to decrease oxybutinine dosage and exclude side effects being the result of its application.
EFFECT: higher efficiency of therapy.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING IMPERATIVE INCONTINENCE OF URINE | 2005 |
|
RU2283122C1 |
| METHOD FOR TREATING HYPERACTIVITY OF URINARY BLADDER | 2001 |
|
RU2193401C1 |
| METHOD FOR TREATING CHILDREN FOR NEUROGENOUS URINARY BLADDER HYPERREFLEXIA | 2003 |
|
RU2250784C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING URINARY DISTURBANCES | 2012 |
|
RU2497504C1 |
| METHOD FOR INCREASING A BLADDER'S RESERVOIR FUNCTION AT CHRONIC CYSTITIS | 2001 |
|
RU2194501C1 |
| APPLICATION OF 10-[(3R)-1-AZABICYCLO[2,2,2]OCT-3-YLMETHTYL]-10H-PHENOTHIAZINE FOR PREPARING DRUG SELECTIVELY INHIBITING MUSCARINE RECEPTORS M1L, M2 AND M3 | 2007 |
|
RU2449794C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING UROGENITAL DISEASES | 2008 |
|
RU2375064C1 |
| DRUG DELIVERY SYSTEMS AND METHODS FOR TREATMENT OF BLADDER VOIDING DYSFUNCTION AND OTHER LOWER URINARY TRACT DISORDERS BY USING TROSPIUM | 2013 |
|
RU2670749C9 |
| METHOD FOR TREATING NEUROGENIC URINARY BLADDER DYSFUNCTION CASES | 2004 |
|
RU2295364C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING DISEASES OF LOWER PART OF GENITOURINARY SYSTEM | 2010 |
|
RU2428173C1 |
